Hepatocellular carcinoma (HCC) is a primary malignant liver tumor originating from
hepatocytes which has a very poor prognosis and is ranked the sixth most common cancer …

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related morbidity and
mortality worldwide. Most patients are diagnosed with advanced disease, limiting their …

Hepatocellular carcinoma (HCC) is the most common primary malignant tumour of the liver,
and is globally considered to be a major causes of cancer-associated mortality. The early …

Hepatocellular carcinoma (HCC) is the sixth commonest form of cancer and is the third
commonest form of cancer related death worldwide. The development of HCC is closely …

Introduction: Globally, the incidence, as well as mortality, related to hepatocellular
carcinoma (HCC) is on the rise, owing to relatively few curative options. Underlying cirrhosis …

Hepatocellular carcinoma (HCC) is ranked as the 5 th common type of cancer worldwide
and is considered as the 3 rd common reason for cancer-related deaths. HCC often occurs …

Highlights•The incidence of HCC will continue to rise.•HCC is curable at an early
stage.•New locoregional treatments such as radioembolisation are showing impressive …

Hepatocellular carcinoma (HCC) is the fourth-leading cause of cancer-related mortality
worldwide and the fastest-rising cause of cancer-related death in the United States. Given …

Overview Oncology drug development has recently introduced new systemic treatment
options for hepatocellular carcinoma (HCC). Here we consider the general approaches to …

Hepatocellular carcinoma (HCC) is an increasing health problem, representing the second
cause of cancer-related mortality worldwide. The major risk factor for HCC is cirrhosis. In …